Company Filing History:
Years Active: 2018-2024
Title: Innovations of Xiaoling Lu
Introduction
Xiaoling Lu is a notable inventor based in Whippany, NJ (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 8 patents, showcasing his innovative approach to developing new compounds and methods for medical applications.
Latest Patents
Among his latest patents is a significant invention related to antiproliferative compounds and methods of use thereof. This patent details a compound identified as 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or its enantiomers, mixtures of enantiomers, tautomers, or pharmaceutically acceptable salts. The methods described in this patent focus on treating, preventing, or managing multiple myeloma using these compounds. Additionally, the patent includes pharmaceutical compositions comprising these compounds and outlines methods for their use.
Career Highlights
Xiaoling Lu has had a distinguished career, working with prominent companies in the pharmaceutical industry. He has been associated with Celgene Corporation and Signal Pharmaceuticals, Inc., where he contributed to various innovative projects and research initiatives.
Collaborations
Throughout his career, Xiaoling has collaborated with several talented individuals, including Hon-Wah Man and Nanfei Zou, who have played significant roles in his research endeavors.
Conclusion
Xiaoling Lu's work in developing antiproliferative compounds and his contributions to the pharmaceutical industry highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving treatment options for serious health conditions, particularly multiple myeloma.